China Corruption Charges Against GSK Exec Still Worry MNC Peers
This article was originally published in PharmAsia News
Executive Summary
Nearly a year later, China's crackdown on corruption allegations lodged against drug makers, beginning with GlaxoSmithKline, continues to cause concern among foreign executives of other global drug makers.